Title : Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Pub. Date : 2010 Sep

PMID : 20585851






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens